| 1 |
Meng Z, Geng X, Lin X, Wang Z, Chen D, Liang H, Zhu Y, Sui Y. A prospective diagnostic and prognostic biomarker for hepatocellular carcinoma that functions in glucose metabolism regulation: Solute carrier family 37 member 3. Biochim Biophys Acta Mol Basis Dis 2023;1869:166661. [PMID: 36773462 DOI: 10.1016/j.bbadis.2023.166661] [Reference Citation Analysis]
|
| 2 |
Lyon A, Tripathi R, Meeks C, He D, Wu Y, Liu J, Wang C, Chen J, Zhu H, Mukherjee S, Ganguly S, Plattner R. ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization. Cancers (Basel) 2023;15. [PMID: 36765910 DOI: 10.3390/cancers15030954] [Reference Citation Analysis]
|
| 3 |
Bu H, Song Q, Zhang J, Wei Y, Liu B. Development of a Novel KCNN4-Related ceRNA Network and Prognostic Model for Renal Clear Cell Carcinoma. Analytical Cellular Pathology 2023;2023:1-26. [DOI: 10.1155/2023/2533992] [Reference Citation Analysis]
|
| 4 |
Azzarito G, Henry M, Rotshteyn T, Leeners B, Dubey RK. Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. Cells 2023;12. [PMID: 36766731 DOI: 10.3390/cells12030389] [Reference Citation Analysis]
|
| 5 |
Li M, Tian P, Zhao Q, Ma X, Zhang Y. Potassium channels: Novel targets for tumor diagnosis and chemoresistance. Front Oncol 2022;12:1074469. [PMID: 36703789 DOI: 10.3389/fonc.2022.1074469] [Reference Citation Analysis]
|
| 6 |
Cortés Franco KD, Brakmann IC, Feoktistova M, Panayotova-Dimitrova D, Gründer S, Tian Y. Aggressive migration in acidic pH of a glioblastoma cancer stem cell line in vitro is independent of ASIC and K(Ca)3.1 ion channels, but involves phosphoinositide 3-kinase. Pflugers Arch 2023;475:405-16. [PMID: 36522586 DOI: 10.1007/s00424-022-02781-w] [Reference Citation Analysis]
|
| 7 |
Azzarito G, Kurmann L, Leeners B, Dubey RK. Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence. Cells 2022;11:2967. [DOI: 10.3390/cells11192967] [Reference Citation Analysis]
|
| 8 |
Fan J, Tian R, Yang X, Wang H, Shi Y, Fan X, Zhang J, Chen Y, Zhang K, Chen Z, Li L. KCNN4 Promotes the Stemness Potentials of Liver Cancer Stem Cells by Enhancing Glucose Metabolism. IJMS 2022;23:6958. [DOI: 10.3390/ijms23136958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 9 |
Chen S, Su X, Mo Z. KCNN4 is a Potential Biomarker for Predicting Cancer Prognosis and an Essential Molecule that Remodels Various Components in the Tumor Microenvironment: A Pan-Cancer Study. Front Mol Biosci 2022;9:812815. [DOI: 10.3389/fmolb.2022.812815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Liu H, Wang H, Dong A, Huo X, Wang H, Wang J, Si J. The Inhibition of Gastric Cancer Cells’ Progression by 23,24-Dihydrocucurbitacin E through Disruption of the Ras/Raf/ERK/MMP9 Signaling Pathway. Molecules 2022;27:2697. [DOI: 10.3390/molecules27092697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Zhang X, Yi X, Zhang Q, Tang Y, Lu Y, Liu B, Pan Z, Wang G, Feng W. Microcystin-LR induced microfilament rearrangement and cell invasion by activating ERK/VASP/ezrin pathway in DU145 cells. Toxicon 2022;210:148-54. [DOI: 10.1016/j.toxicon.2022.02.023] [Reference Citation Analysis]
|
| 12 |
Lobl MB, Clarey DD, Higgins S, Sutton A, Wysong A. Sequencing of cutaneous squamous cell carcinoma primary tumors and patient-matched metastases reveals ALK as a potential driver in metastases and low mutational concordance in immunocompromised patients. JID Innovations 2022. [DOI: 10.1016/j.xjidi.2022.100122] [Reference Citation Analysis]
|
| 13 |
Du B, Su F, Wang H, Liang H, Song X, Shao Z, Wei Y. Identification of potential core genes at single-cell level contributing to pathogenesis of pancreatic ductal adenocarcinoma through bioinformatics analysis. CBM 2022. [DOI: 10.3233/cbm-210271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Huang C, Chen XM, Pollock CA. KCa3.1 in diabetic kidney disease. Curr Opin Nephrol Hypertens 2022;31:129-34. [PMID: 34710887 DOI: 10.1097/MNH.0000000000000751] [Reference Citation Analysis]
|
| 15 |
Ponnusamy M, Rajagopal S. Targeting ion channels in hepatic cancer. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 2022. [DOI: 10.1016/b978-0-323-98807-0.00012-0] [Reference Citation Analysis]
|
| 16 |
Liu Z, Lu J, Fang H, Sheng J, Cui M, Yang Y, Tang B, Zhang X. m6A Modification-Mediated DUXAP8 Regulation of Malignant Phenotype and Chemotherapy Resistance of Hepatocellular Carcinoma Through miR-584-5p/MAPK1/ERK Pathway Axis. Front Cell Dev Biol 2021;9:783385. [PMID: 34957112 DOI: 10.3389/fcell.2021.783385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Wu L, Lian W, Zhao L. Calcium signaling in cancer progression and therapy. FEBS J 2021. [PMID: 34288422 DOI: 10.1111/febs.16133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Kim HW, Lee MW, Lee JH, Kim MY. Comparison of the Effect of Oral Versus Intravenous Bisphosphonate Administration on Osteoclastogenesis in Advanced-Stage Medication-Related Osteonecrosis of the Jaw Patients. J Clin Med 2021;10:2988. [PMID: 34279472 DOI: 10.3390/jcm10132988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Cui X, Li X, He Y, Yu J, Fu J, Song B, Zhao RC. Combined NOX/ROS/PKC Signaling Pathway and Metabolomic Analysis Reveals the Mechanism of TRAM34-Induced Endothelial Progenitor Cell Senescence. Stem Cells Dev 2021;30:671-82. [PMID: 33906436 DOI: 10.1089/scd.2021.0062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Chen S, Wang C, Su X, Dai X, Li S, Mo Z. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma. Transl Androl Urol 2021;10:2454-70. [PMID: 34295732 DOI: 10.21037/tau-21-332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 21 |
Qin L, Qin J, Lv X, Yin C, Zhang Q, Zhang J. MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma. Oncol Lett 2021;22:549. [PMID: 34093770 DOI: 10.3892/ol.2021.12810] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 22 |
Qiu YA, Xiong J, Fu Q, Dong Y, Liu M, Peng M, Jin W, Zhou L, Xu X, Huang X, Fu A, Xu G, Tu G, Yu T. GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma. Front Oncol 2021;11:638171. [PMID: 33767999 DOI: 10.3389/fonc.2021.638171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Stock C. How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32875386 DOI: 10.1007/112_2020_41] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 24 |
Wen J, Lin B, Lin L, Chen Y, Wang O. KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression. Aging (Albany NY) 2020;12:16437-56. [PMID: 32857728 DOI: 10.18632/aging.103710] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
